InvestorsHub Logo
Followers 12
Posts 788
Boards Moderated 0
Alias Born 09/26/2018

Re: VuBru post# 213807

Wednesday, 09/11/2019 5:27:49 PM

Wednesday, September 11, 2019 5:27:49 PM

Post# of 423548
Maybe. But if that was the case the company would have clarified easily in their response to me. They deferred and mentioned they're working on an answer.

Repatha was approved as a monotherapy for statin intolerant patients. Why wouldn't V at least pursue that path?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News